Small RNAs: Pseudogenes act as microRNA decoys.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Genome-wide time-to-event analysis on smoking progression stages in a family-based study.Brain and behavior · 2016
   Article
2. Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines.Cell journal · 2016
   Article
3. Regulating the many to benefit the few: role of weak small RNA targets.Biophysical journal · 2013
   Article
4. Decoy activity through microRNAs: the therapeutic implications.Expert opinion on biological therapy · 2012
   Review
5. Identification and functional demonstration of miRNAs in the fungus Cryptococcus neoformans.PloS one · 2012
   Article

Corrections and comments

• Comment on
  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.